Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Treasury Shares (2022 - 2025)

SOPHiA GENETICS's Treasury Shares history spans 4 years, with the latest figure at -$1.2 million for Q4 2025.

  • On a quarterly basis, Treasury Shares fell 73.5% to -$1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.2 million, a 73.5% decrease, with the full-year FY2025 number at -$1.2 million, down 73.5% from a year prior.
  • Treasury Shares hit -$1.2 million in Q4 2025 for SOPHiA GENETICS, down from -$632000.0 in the prior quarter.
  • Over the last five years, Treasury Shares for SOPH hit a ceiling of -$112000.0 in Q1 2023 and a floor of -$1.2 million in Q4 2025.
  • Historically, Treasury Shares has averaged -$524812.5 across 4 years, with a median of -$642000.0 in 2023.
  • Biggest five-year swings in Treasury Shares: rose 15.79% in 2023 and later plummeted 469.64% in 2024.
  • Tracing SOPH's Treasury Shares over 4 years: stood at -$117000.0 in 2022, then crashed by 452.14% to -$646000.0 in 2023, then dropped by 8.67% to -$702000.0 in 2024, then plummeted by 73.5% to -$1.2 million in 2025.
  • Business Quant data shows Treasury Shares for SOPH at -$1.2 million in Q4 2025, -$632000.0 in Q3 2025, and -$648000.0 in Q2 2025.